These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 799997)

  • 1. Comparative efficacy and safety of cephradine and cephalexin in children.
    Mouallem R
    J Int Med Res; 1976; 4(4):265-71. PubMed ID: 799997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of cephradine and cephalexin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus.
    Hubsher JA; Gadebusch HH; Itkin AG
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):579-88. PubMed ID: 819217
    [No Abstract]   [Full Text] [Related]  

  • 3. Cephradine and cephalexin in the treatment of children with bacterial pneumonia.
    Alban J; Caloza DL
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):539-45. PubMed ID: 241608
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of cepharadine and cephalexin in the treatment of respiratory and urinary tract infections.
    Mogabgab WJ
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):421-32. PubMed ID: 4284
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous use of cephradine and cefazolin against serious infections.
    Caloza DL; Semar RW; Bernfeld GE
    Antimicrob Agents Chemother; 1979 Jan; 15(1):119-22. PubMed ID: 426499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative double-blind study of cefroxadine and cephalexin in the treatment of complicated urinary tract infection].
    Kamidono S; Harada M; Ishigami J; Takasaki N; Miyazaki S; Furusawa T; Mizunoe Y; Ito K; Momose S; Nakamuta S
    Jpn J Antibiot; 1983 Sep; 36(9):2571-94. PubMed ID: 6361324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double-blind comparative trial of cefroxadine and cephalexin in the treatment of acute suppurative otitis media and acute exacerbation of chronic suppurative otitis media].
    Baba S; Murai K; Kinoshita H; Kawai T; Koyama K; Tsukiyama M; Maruo T; Wada K; Inagaki M; Matsushita T
    Jpn J Antibiot; 1983 Sep; 36(9):2595-634. PubMed ID: 6361325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of cefroxadine and cephalexin in urinary tract infections: a double-blind comparative study.
    Ahrens T; Naber KG
    Infection; 1983; 11(1):25-30. PubMed ID: 6341252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of roxithromycin (RU-965) versus cephradine in pneumococcal pneumonia.
    Zeluff BJ; Lowe P; Koornhof HJ; Gentry LO
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):69-71. PubMed ID: 3132383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice daily treatment of pneumonia with cephradine.
    Caloza DL; Bernfeld GE
    J Maine Med Assoc; 1977 May; 68(5):152-5. PubMed ID: 325160
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study Group.
    Tack KJ; Keyserling CH; McCarty J; Hedrick JA
    Antimicrob Agents Chemother; 1997 Apr; 41(4):739-42. PubMed ID: 9087480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind investigation of cefroxadine (CGP 9000) versus cephalexin in urinary tract infection.
    Hess J; Gammelgaard P; Holst B; Rasmussen F; Thomsen VF
    Infection; 1984; 12(4):270-3. PubMed ID: 6436182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of cefroxadine dry syrup in the management of acute skin infections in children (author's transl)].
    Arata J; Yamamoto Y; Hagiyama M; Nohara N; Suwaki M; Miyoshi K; Masuda T; Nakagawa S; Ueki H; Nakakita T; Kashiwa N; Tokumaru S; Arakawa K; Take M; Nishihara O; Masuda T; Hiramatsu H; Yamada M; Nishimoto M; Tada J; Umemura S; Fujimoto W; Tanaka A; Okuma N
    Jpn J Antibiot; 1981 Dec; 34(12):1748-64. PubMed ID: 7038191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical comparison of cefuroxime axetil, cephalexin and cefadroxil in the treatment of patients with primary infections of the skin or skin structures.
    Gooch WM; Kaminester L; Cole GW; Binder R; Morman MR; Swinehart JM; Wisniewski M; Yilmaz HM; Collins JJ
    Dermatologica; 1991; 183(1):36-43. PubMed ID: 1769413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of cephradine oral suspension in the treatment of bacterial infections of infants and children.
    Lipman RP; Silverman W
    Clin Pediatr (Phila); 1977 Sep; 16(9):835-7. PubMed ID: 330074
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cefroxadine and cephalexin in urinary tract infections. Kinetics of germ elimination].
    Naber KG; Ahrens T
    Fortschr Med; 1982 Oct; 100(39):1827-31. PubMed ID: 6759334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials of cefroxadine on skin and soft tissue infections in the field of pediatrics (author's transl)].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Nishiyama T; Fujimoto T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Tomoishi T; Takenaka S; Kamezaki K; Ohyama K; Takasaki K; Oki S; Yoshinaga Y; Nagai T; Kawano N; Toyoda J; Shimohida T
    Jpn J Antibiot; 1981 Dec; 34(12):1732-46. PubMed ID: 7038190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group.
    Tack KJ; Littlejohn TW; Mailloux G; Wolf MM; Keyserling CH
    Clin Ther; 1998; 20(2):244-56. PubMed ID: 9589816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
    Parish LC; Jorizzo JL; Breton JJ; Hirman JW; Scangarella NE; Shawar RM; White SM;
    J Am Acad Dermatol; 2006 Dec; 55(6):1003-13. PubMed ID: 17097398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefadroxil. A review of its antibacterial, pharmacokinetic and therapeutic properties in comparison with cephalexin and cephradine.
    Tanrisever B; Santella PJ
    Drugs; 1986; 32 Suppl 3():1-16. PubMed ID: 3542485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.